Drug
Gliclazide MR And Insulin Glargine
Gliclazide MR And Insulin Glargine: highest development phase Post-Market, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Gliclazide MR and Insulin Glargine Injection NCT00736515 | Post-Market | Type 2 Diabetes |
Latest
No recent events.
Follow Gliclazide MR And Insulin Glargine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.